Aiming for a better understanding and management of cancer-related fatigue

Elisabeth C. W. Neefjes; Maurice J. D. L. van der Vorst; Susanne Blauwhoff-Buskermolen; Henk M. W. Verheul

doi:10.1634/theoncologist.2013-0076

Aiming for a better understanding and management of cancer-related fatigue

Elisabeth C. W. Neefjes
, Maurice J. D. L. van der Vorst
, Susanne Blauwhoff-Buskermolen
, Henk M. W. Verheul

Amsterdam UMC - Vrije Universiteit Amsterdam

Research output: Contribution to journal › Review article › Academic › peer-review

Abstract

Cancer-related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in the general population, with a prevalence of about 30%, up to 99% of patients with cancer have fatigue of more intense severity. CRF is directly related to the biology of cancer, but it can also be caused by anticancer treatment. We reviewed current evidence about the potential pathophysiological mechanisms causing CRF. Clinical methods to determine the presence and severity of CRF and potential treatment options to reduce CRF will be discussed. After reading this review, the reader will have knowledge of the current understanding of CRF and will be able to give evidence-based advice to patients with CRF. © AlphaMed Press 2013.

Original language	English
Pages (from-to)	1135-1143
Journal	oncologist
Volume	18
Issue number	10
DOIs	https://doi.org/10.1634/theoncologist.2013-0076
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1634/theoncologist.2013-0076

Cite this

@article{a7c6ccd0b62f49599b5f0955238f3236,

title = "Aiming for a better understanding and management of cancer-related fatigue",

abstract = "Cancer-related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in the general population, with a prevalence of about 30\%, up to 99\% of patients with cancer have fatigue of more intense severity. CRF is directly related to the biology of cancer, but it can also be caused by anticancer treatment. We reviewed current evidence about the potential pathophysiological mechanisms causing CRF. Clinical methods to determine the presence and severity of CRF and potential treatment options to reduce CRF will be discussed. After reading this review, the reader will have knowledge of the current understanding of CRF and will be able to give evidence-based advice to patients with CRF. {\textcopyright} AlphaMed Press 2013.",

author = "Neefjes, \{Elisabeth C. W.\} and \{van der Vorst\}, \{Maurice J. D. L.\} and Susanne Blauwhoff-Buskermolen and Verheul, \{Henk M. W.\}",

year = "2013",

doi = "10.1634/theoncologist.2013-0076",

language = "English",

volume = "18",

pages = "1135--1143",

journal = "oncologist",

issn = "1083-7159",

publisher = "AlphaMed Press",

number = "10",

}

TY - JOUR

T1 - Aiming for a better understanding and management of cancer-related fatigue

AU - Neefjes, Elisabeth C. W.

AU - van der Vorst, Maurice J. D. L.

AU - Blauwhoff-Buskermolen, Susanne

AU - Verheul, Henk M. W.

PY - 2013

Y1 - 2013

N2 - Cancer-related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in the general population, with a prevalence of about 30%, up to 99% of patients with cancer have fatigue of more intense severity. CRF is directly related to the biology of cancer, but it can also be caused by anticancer treatment. We reviewed current evidence about the potential pathophysiological mechanisms causing CRF. Clinical methods to determine the presence and severity of CRF and potential treatment options to reduce CRF will be discussed. After reading this review, the reader will have knowledge of the current understanding of CRF and will be able to give evidence-based advice to patients with CRF. © AlphaMed Press 2013.

AB - Cancer-related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in the general population, with a prevalence of about 30%, up to 99% of patients with cancer have fatigue of more intense severity. CRF is directly related to the biology of cancer, but it can also be caused by anticancer treatment. We reviewed current evidence about the potential pathophysiological mechanisms causing CRF. Clinical methods to determine the presence and severity of CRF and potential treatment options to reduce CRF will be discussed. After reading this review, the reader will have knowledge of the current understanding of CRF and will be able to give evidence-based advice to patients with CRF. © AlphaMed Press 2013.

UR - https://www.scopus.com/pages/publications/84886045718

UR - https://www.ncbi.nlm.nih.gov/pubmed/24037979

U2 - 10.1634/theoncologist.2013-0076

DO - 10.1634/theoncologist.2013-0076

M3 - Review article

C2 - 24037979

SN - 1083-7159

VL - 18

SP - 1135

EP - 1143

JO - oncologist

JF - oncologist

IS - 10

ER -

Aiming for a better understanding and management of cancer-related fatigue

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this